ProKidney is a clinical-stage biotechnology company developing cell therapy candidates for chronic kidney disease, with a focus on preserving kidney function and delaying dialysis. The company is based in the United States.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!